Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S

Release Summary

Otsuka and Lundbeck Present Data at ACNP Annual Meeting on Long-Acting Injectable Aripiprazole as a Potential Maintenance Treatment for Bipolar I Disorder

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S